Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA
Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA
Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis products
Clever Leaves is the first and only medicinal cannabis company globally who has GMP certifications from the EU, Colombia and Brazil
跨國運營商已獲得ANVISA頒發的巴西GMP認證，用於生產大麻產品
Clever Leaves是全球第一家也是唯一一家獲得歐盟、哥倫比亞和巴西GMP認證的藥用大麻公司
TOCANCIPÁ, Colombia, May 16, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that the Company has received the Brazilian GMP certification by ANVISA, the Brazilian Health Regulatory Agency, to manufacture cannabis products for Brazilian patients.
哥倫比亞託坎西帕2023年5月16日（GLOBE NEWSWIRE）——全球藥用大麻公司Clever Leaves Holdings Inc.（納斯達克股票代碼：CLVR，CLVRW）今天宣佈，該公司已獲得巴西衛生監管機構ANVISA的巴西GMP認證，可以爲巴西患者生產大麻產品。
Similar to the strict standards of the EU-GMP certification, ANVISA's Brazilian-GMP certification ensures that patients receive the highest quality of medicine by preventing cases of product contamination, variations in compounds concentrations, mix-ups, incorrect labeling, and more. The certification is required for the manufacturing and commercialization of cannabis products in Brazil. Clever Leaves' Colombia facility being awarded Brazilian-GMP marks the company's fifth international official certification and further attests to the high-quality and premium standard practices that Clever Leaves upholds in its production. Clever Leaves is the first and only medicinal cannabis company globally who has GMP certifications from the EU, Colombia and Brazil.
與歐盟GMP認證的嚴格標準類似，ANVISA的巴西GMP認證通過防止產品污染、化合物濃度變化、混淆、標籤錯誤等情況，確保患者獲得最高質量的藥物。在巴西製造和商業化大麻產品需要認證。Clever Leaves哥倫比亞工廠被授予巴西GMP標誌着該公司的第五次國際官方認證，也進一步證明了Clever Leaves在其生產中堅持的高質量和優質的標準規範。Clever Leaves是全球第一家也是唯一一家獲得歐盟、哥倫比亞和巴西GMP認證的藥用大麻公司。
"The awarding of Brazilian-GMP certification signifies a major milestone for Clever Leaves by further highlighting our commitment to producing high-quality and safe cannabis products that are trusted internationally and meet the highest regulatory standards. The Brazilian market in particular has the potential to become the largest cannabis market in Latin America and one of the largest globally. We look forward to further developing our presence in Brazil through our partners, with whom we are already distributing finished cannabis products to medical patients in the country," said Andres Fajardo, CEO of Clever Leaves.
“獲得巴西GMP認證標誌着Clever Leaves的一個重要里程碑，它進一步凸顯了我們對生產國際信賴並符合最高監管標準的高質量和安全大麻產品的承諾。特別是巴西市場有可能成爲拉丁美洲最大的大麻市場和全球最大的大麻市場之一。Clever Leaves首席執行官安德烈斯·法哈多說，我們期待通過我們的合作伙伴進一步發展我們在巴西的業務，我們已經與他們一起向該國的醫療患者分發大麻成品。
Brazil currently has a population of over 210 million and has a regulatory framework for the use of medical cannabis products authorized under the RDC 327/2019. In addition to making Clever Leaves one of the few cannabis companies outside of Brazil to receive ANVISA's GMP certification, this certification, along with the EU-GMP, will allow Clever Leaves to expand operations into new and existing markets throughout the 5 continents that recognize international GMP standards and enable patient access to Clever Leaves' high-quality products.
巴西目前人口超過2.1億，並且擁有RDC 327/2019授權的醫用大麻產品的使用監管框架。除了使Clever Leaves成爲巴西以外爲數不多的獲得ANVISA的GMP認證的大麻公司之一外，該認證以及歐盟GMP還將使Clever Leaves能夠將業務擴展到五大洲認可國際GMP標準的新市場和現有市場，使患者能夠獲得Clever Leaves的高質量產品。
About Clever Leaves Holdings Inc.
Clever Leaves is a global medicinal cannabis company. Its operations in Colombia produce cannabinoid active pharmaceutical ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world's most stringent pharmaceutical quality certifications. For more information, please visit
關於 Clever Leaves 控股公司
Clever Leaves 是一家全球藥用大麻公司。其在哥倫比亞的業務爲全球不斷增長的B2B客戶羣生產大麻素活性藥物成分（API）和花卉和提取物形式的成品。Clever Leaves旨在通過利用環境可持續、ESG友好、工業規模和低成本的生產方法以及世界上最嚴格的藥品質量認證，來顛覆傳統的大麻生產行業。欲瞭解更多信息，請訪問
Press Contacts:
Rich DiGregorio
KCSA Strategic Communications
+1-856-889-7351
cleverleaves@kcsa.com
新聞聯繫人：
裏奇·迪格雷戈里奧
KCSA 戰略傳播
+1-856-889-7351
cleverleaves@kcsa.com
譯文內容由第三人軟體翻譯。